Author(s):
Mihir Kaushiksinh Thakor, Kantilal Narkhede, Anuradha Prajapati, Sachin Narkhede, Shailesh Luhar, Tej Patel
Email(s):
mihirpharma5@gmail.com
DOI:
10.52711/2231-5659.2026.00047 
Address:
Mihir Kaushiksinh Thakor*, Kantilal Narkhede, Anuradha Prajapati, Sachin Narkhede, Shailesh Luhar, Tej Patel
Smt. B.N.B Swaminarayan Pharmacy College, Salvav-Vapi, Gujarat, 396191.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2026
ABSTRACT:
Rheumatoid arthritis (RA), an autoimmune disease, has major adverse effects on quality of life. This condition is severe. A new and hopeful technique for treating RA symptoms has been suggested by chronotherapy, which involves medication interactions with biological rhythms. Cubosomes are carriers that utilize nanoscale lipids, which have remarkable biocompatibility and sustained release properties for transdermal drug delivery. Significant advancements in pharmaceutical formulation design have been made through the use of artificial intelligence (AI) to develop new drug delivery systems. This paper explores the reasoning, methodology and possible clinical uses of AI-guided formulation of transdermal cubosomes for the chronotherapeutic management of RA.
Cite this article:
Mihir Kaushiksinh Thakor, Kantilal Narkhede, Anuradha Prajapati, Sachin Narkhede, Shailesh Luhar, Tej Patel. Al-Guided Formulation of Transdermal Cubosomes for Chronotherapeutic Management of Rheumatoid Arthritis. Asian Journal of Research in Pharmaceutical Sciences. 2026; 16(3):316-2. doi: 10.52711/2231-5659.2026.00047
Cite(Electronic):
Mihir Kaushiksinh Thakor, Kantilal Narkhede, Anuradha Prajapati, Sachin Narkhede, Shailesh Luhar, Tej Patel. Al-Guided Formulation of Transdermal Cubosomes for Chronotherapeutic Management of Rheumatoid Arthritis. Asian Journal of Research in Pharmaceutical Sciences. 2026; 16(3):316-2. doi: 10.52711/2231-5659.2026.00047 Available on: https://www.ajpsonline.com/AbstractView.aspx?PID=2026-16-3-16
11. REFERENCE:
1 Huanbutta K, Burapapadh K, Kraisit P, Sriamornsak P, Ganokratanaa T, Sangnim T. Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. Eur J Pharm Sci. 2024; 203:106938.
2 Noorain S, Srivastava V, Parveen B, Parveen R. Artificial intelligence in drug formulation development: Applications and future prospects. Curr Drug Metab. 2023; 24(9): 622–34.
3 Sachan AK, Sachan NK, Kumar S. Role of artificial intelligence in quality by design for pharmaceuticals. Curr Pharm Biotechnol. 2023; 24(12): 1509–22.
4 Kim HJ, Lee SH, Park CH. Artificial intelligence in pharmaceutical sciences: Revolutionizing formulation design and quality control. J Pharm Investig. 2023; 53(4): 567–82.
5 Choi YJ, Kim SY. Machine learning approaches for quality by design in pharmaceutical formulation: A review. Asian J Pharm Sci. 2024; 19(2): 100912.
6 Patel M, Chavda H. Application of artificial intelligence in quality by design for pharmaceutical development. Indian J Pharm Sci. 2022;84(5):1123–35.
7 Nath S, Yata VK. Recent advances in the use of cubosomes as drug carriers with special emphasis on topical applications. J Lipids. 2024; 2024: 9781354.
8 Shen Q, Wang Y, Du Y. Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis. Int J Pharm. 2023; 635:122698.
9 Li J, Wang X, Zhang Q. Artificial intelligence in pharmaceutical manufacturing: Enhancing quality by design. Chin J Chem Eng. 2023; 65:123–34.
10 Chen Y, Liu H. Integrating artificial intelligence with quality by design for advanced pharmaceutical formulation. Acta Pharm Sin B. 2023; 13(9): 3789–802.
11 Tanaka R, Sato K. Artificial intelligence in pharmaceutical formulation: A quality by design perspective. J Pharm Sci (Japan). 2023; 143(6): 521–34.
12 Kumar P, Jain V. Role of artificial intelligence in optimizing pharmaceutical formulations under QbD framework. Indian J Pharm Educ Res. 2022; 56(4): 987–96.
13 Jiang T, Xie Y, Sun C. The dexamethasone acetate cubosomes as a potential transdermal delivery system for treating skin inflammation. J Drug Deliv Sci Technol. 2023; 79:104123.
14 Nguyen TH, Tran VD. AI-driven quality by design in pharmaceutical formulation: Opportunities and challenges. J Asian Pharm Technol. 2024; 12(3): 89–102.
15 Abbas F, Salehian M, Hou P, Moores J, Goldie J, Tsioutsios A, et al. Accelerated medicines development using a Digital Formulator and a Self-Driving Tableting DataFactory. arXiv [Preprint]. 2025 Mar 20; Available from: arXiv:2503.17411.